Posted On: 10/31/2014 12:42:45 PM
Post# of 9144
The drama that is currently unfolding with Kacy Hickox would be unnecessary if the N-Assay (V) were already available for ebola.
We know that any Company in discussions with Nanologix will realize quickly that the N-Assay is cheap, easy to use and highly sensitive. The next obvious revelation to them should be that the N-Assay can be applied to a potentially wide variety of viruses followed by a pursuit N-Assay (V) kits for those that are easily communicated with high mortality rates.
Then it circles back to the N-Assay (
. Eyes should pop when they realize the potential revenue potential. Add the Flatpack and BNP and hopefully, we either get a deep pocketed partner committed to help bring Nanologix products to market or a new owner.
We know that any Company in discussions with Nanologix will realize quickly that the N-Assay is cheap, easy to use and highly sensitive. The next obvious revelation to them should be that the N-Assay can be applied to a potentially wide variety of viruses followed by a pursuit N-Assay (V) kits for those that are easily communicated with high mortality rates.
Then it circles back to the N-Assay (
. Eyes should pop when they realize the potential revenue potential. Add the Flatpack and BNP and hopefully, we either get a deep pocketed partner committed to help bring Nanologix products to market or a new owner.
(0)
(0)
